COVID-19 vaccine hesitancy among the vaccinated: a cross-sectional survey
Authors:
- Mengyuan ChenMCMengyuan Chen
- Xiang XueXXXiang Xue
- Faguang LuoFLFaguang Luo
- Yongba ChenYCYongba Chen
- Wenfeng ZhanWZWenfeng Zhan
- Jian ShuaiJSJian Shuai
- Dan XuDXDan Xu
- Bo LvBLBo Lv
Open Access
- 1 October 2025
- journal article
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (10) , 8678-8689
Abstract
Background: Coronavirus disease 2019 (COVID-19) vaccines play a crucial role in preventing serious complications, including intensive care unit (ICU) and hospital admissions, and in reducing the symptoms associated with the infection. However, vaccine hesitancy has been identified as a significant barrier to COVID-19 vaccination. This survey aimed to investigate vaccine hesitancy by exploring and identifying the enablers and barriers to receiving the second dose of the COVID-19 vaccine in a small cohort who had already received a first dose of the COVID-19 vaccine. Methods: A cross-sectional survey was conducted with 959 individuals who received a second dose of the COVID-19 vaccine at Guangdong Provincial People’s Hospital, from February 18 to February 23, 2021. The survey investigated the socio-demographic characteristics of the participants, and the enablers and barriers to the COVID-19 vaccination. Results: In total, 959 individuals completed the survey. The participants had an average age of 43.23±9.86 years, and 80.0% were male, 84.8% were married, and 34.9% had additional private commercial insurance. In terms of vaccine complications, 11.5% reported mild allergic reactions, and 8.7% reported hypertension. Among the participants, 74.7% agreed to receive a second dose of the COVID-19 vaccine. A multivariate logistic regression analysis of the participants who received the first dose of the vaccine revealed a higher level of vaccine acceptance among males [odds ratio (OR) =0.58; P=0.005], older individuals (OR =0.97; P=0.001), those who were married (OR =0.57; P=0.007), those with additional private commercial insurance (OR =0.65; P=0.02), and those who had many colleagues and friends who had received the vaccine (OR =0.58; P=0.007). Conversely, those who misunderstood the safety profile and side effects of the vaccine (OR =4.34; PConclusions: COVID-19 vaccine hesitancy was lower among males, older individuals, those who were married, those with additional private commercial insurance, and those who had a number of supportive colleagues and friends who had received the vaccine. Misunderstandings of the safety profile of the vaccine and the related adverse events were associated with a higher rate of vaccine hesitancy. Education efforts should seek to reduce vaccine hesitancy by improving understandings of the safety profile and adverse events related to the COVID-19 vaccine, emphasizing the benefit-to-risk ratio both at the individual level and from a socioeconomic perspective. Reducing vaccine hesitancy will increase the uptake of the COVID-19 vaccine, which in turn will reduce morbidity, mortality, and hospitalization, including ICU and critical care admission, thus decreasing the social and economic burden.Keywords
This publication has 31 references indexed in Scilit:
- Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19The European Journal of Health Economics, 2020
- A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- Addressing Vaccine Hesitancy in China: A Scoping Review of Chinese ScholarshipVaccines, 2019
- Understanding influenza vaccine perspectives and hesitancy in university students to promote increased vaccine uptakeHeliyon, 2019
- Vaccine acceptance: Science, policy, and practice in a ‘post-fact’ worldVaccine, 2019
- Addressing vaccine hesitancy: The potential value of commercial and social marketing principles and practicesVaccine, 2015
- Evaluating a County-Sponsored Social Marketing Campaign to Increase Mothers' Initiation of HPV Vaccine for Their Preteen Daughters in a Primarily Rural AreaSocial Marketing Quarterly, 2011
- Risk Perceptions, Worry, or Distrust: What Drives Pregnant Women’s Decisions to Accept the H1N1 Vaccine?Maternal and Child Health Journal, 2010
- Influenza Vaccination Acceptance and Refusal Rates Among Health Care PersonnelSouthern Medical Journal, 2010
- Vaccine Refusal, Mandatory Immunization, and the Risks of Vaccine-Preventable DiseasesNew England Journal of Medicine, 2009